Back
Actinium Pharmaceuticals Vs. Bio-Path Holdings Industry Stock Comparison
Sell
24
ATNM
Actinium Pharmaceuticals
Last Price:
6.97
Seasonality Move:
0.26%
Sell
8
BPTH
Bio-Path Holdings
Last Price:
1.71
Seasonality Move:
0.65%
Sell
24
Actinium Pharmaceuticals (ATNM)
is a Sell
Is Actinium Pharmaceuticals a Buy, Sell or Hold?
- The current Actinium Pharmaceuticals [ATNM] share price is $6.97. The Score for ATNM is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- ATNM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
8
Bio-Path Holdings (BPTH)
is a Sell
Is Bio-Path Holdings a Buy, Sell or Hold?
- The current Bio-Path Holdings [BPTH] share price is $1.71. The Score for BPTH is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
- BPTH is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ATNM Stock Price Chart
What is Actinium Pharmaceuticals's stock price today?
-
The Actinium Pharmaceuticals share price today is $6.97
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATNM is experiencing slight selling pressure.
BPTH Stock Price Chart
What is Bio-Path Holdings's stock price today?
-
The Bio-Path Holdings share price today is $1.71
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPTH is experiencing selling pressure, which indicates risk of future bearish movement.
ATNM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.31 | Sell |
Relative Strength Index (14 RSI): | 36.82 | Sell |
Chaikin Money Flow: | -26939 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.29 - 8.11) | Sell |
Bollinger Bands (100): | (6.93 - 8.89) | Sell |
BPTH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.19 | Sell |
Relative Strength Index (14 RSI): | 34.97 | Sell |
Chaikin Money Flow: | -31487 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.84 - 2.66) | Sell |
Bollinger Bands (100): | (1.84 - 5.76) | Sell |
ATNM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.22 | Sell |
20-day SMA: | 7.58 | Sell |
50-day SMA: | 8.12 | Sell |
200-day SMA: | 6.6 | Buy |
8-day EMA: | 7.23 | Sell |
20-day EMA: | 7.54 | Sell |
50-day EMA: | 7.84 | Sell |
200-day EMA: | 7.32 | Sell |
BPTH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.92 | Sell |
20-day SMA: | 2.13 | Sell |
50-day SMA: | 2.35 | Sell |
200-day SMA: | 6.85 | Sell |
8-day EMA: | 1.9 | Sell |
20-day EMA: | 2.09 | Sell |
50-day EMA: | 2.61 | Sell |
200-day EMA: | 8.4 | Sell |
Actinium Pharmaceuticals Earnings Growth & ATNM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.51 per share, an increase this year of $0.47 per share, and an increase next year of $1.18 per share.
Bio-Path Holdings Earnings Growth & BPTH Earnings Dates
- Analysts estimate an earnings increase this quarter of $5.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $27.87 per share, and an increase next year of $1.88 per share.
Actinium Pharmaceuticals Technical Analysis
Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bio-Path Holdings Technical Analysis
Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |